Download Full Text (863 KB)
Pediatric patients with deficient immune systems or certain chronic medical conditions have an increased risk of acquiring invasive pneumococcal disease.
The 23-valent pneumococcal (PPSV23) vaccine provides protection against 23 pneumococcal serotypes and is recommended for patients aged 2 years or older who are high-risk for invasive pneumococcal disease.
Unfortunately, many high-risk patients are not properly vaccinated due to lack of provider knowledge or understanding of accountability between primary care and specialty providers.
The goal of this project was to improve PPSV23 vaccination rates by 10-20% across multiple Children's Mercy Kansas City specialty divisions.
Pneumococcal Vaccines; Vaccination Coverage; Outpatient Clinics, Hospital; Child, Preschool; Child; Adolescent; Quality Improvement
23-valent pneumococcal vaccine; PPSV23; specialty clinics
Bacterial Infections and Mycoses | Infectious Disease | Pediatrics | Pulmonology | Rheumatology
National Healthcare Quality Week
Moran, Rachel; Harris, Julia G.; Olsen, Claire; El Feghaly, Rana; Olarte, Liset; Blowey, Douglas; and Harris, Luke A., "Improving Pneumococcal Vaccination Rates in High Risk Patients Across Multiple Specialty Divisions" (2019). Posters. 141.